The most significant reductions in CRP were observed in individuals with higher baseline CRP levels, longer intervention durations, and those with T2DM, suggesting stronger anti-inflammatory effects in those with chronic inflammation. This evidence concerns the gene CRP and type 2 diabetes mellitus.